The United States drastically reduced funding for global tuberculosis programs, impacting millions of patients worldwide.
Hundreds of thousands now lack access to crucial testing and medication, leading to increased suffering and disease spread.
This funding cut severely crippled the global tuberculosis treatment infrastructure, especially in Africa and Asia.
The consequences are devastating, resulting in preventable deaths and a resurgence of this deadly infectious disease.
